80 related articles for article (PubMed ID: 3038549)
1. Isolation and characterization of neurokinin A, neurokinin A(3-10) and neurokinin A(4-10) from a neutral water extract of a metastatic ileal carcinoid tumour.
Theodorsson-Norheim E; Jörnvall H; Andersson M; Norheim I; Oberg K; Jacobsson G
Eur J Biochem; 1987 Aug; 166(3):693-7. PubMed ID: 3038549
[TBL] [Abstract][Full Text] [Related]
2. Isolation and characterization of substance P, substance P 5-11, and substance K from two metastatic ileal carcinoids.
Roth KA; Makk G; Beck O; Faull K; Tatemoto K; Evans CJ; Barchas JD
Regul Pept; 1985 Nov; 12(3):185-99. PubMed ID: 2417286
[TBL] [Abstract][Full Text] [Related]
3. Measurement and partial characterization of the multiple forms of neurokinin A-like immunoreactivity in carcinoid tumours.
Conlon JM; Deacon CF; Richter G; Schmidt WE; Stöckmann F; Creutzfeldt W
Regul Pept; 1986 Jan; 13(2):183-96. PubMed ID: 3006157
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide K: a major tachykinin in plasma and tumor tissues from carcinoid patients.
Theodorsson-Norheim E; Norheim I; Oberg K; Brodin E; Lundberg JM; Tatemoto K; Lindgren PG
Biochem Biophys Res Commun; 1985 Aug; 131(1):77-83. PubMed ID: 2412557
[TBL] [Abstract][Full Text] [Related]
5. Tachykinin production by carcinoid tumours in culture.
Norheim I; Wilander E; Oberg K; Theodorsson-Norheim E; Lundqvist ML; Lindgren P; Bergh J
Eur J Cancer Clin Oncol; 1987 Jun; 23(6):689-95. PubMed ID: 3477459
[TBL] [Abstract][Full Text] [Related]
6. Expression of tachykinins by ileal and lung carcinoid tumors assessed by combined in situ hybridization, immunocytochemistry, and radioimmunoassay.
Bishop AE; Hamid QA; Adams C; Bretherton-Watt D; Jones PM; Denny P; Stamp GW; Hurt RL; Grimelius L; Harmar AJ
Cancer; 1989 Mar; 63(6):1129-37. PubMed ID: 2645037
[TBL] [Abstract][Full Text] [Related]
7. Multiple molecular forms of tachykinins in rat spinal cord: a study comparing different extraction methods.
Brodin E; Rosén A; Theodorsson E; Jonczyk A; Sandberg BE; Brodin K
Regul Pept; 1994 Jul; 52(2):97-110. PubMed ID: 7526421
[TBL] [Abstract][Full Text] [Related]
8. Immunoreactive tachykinins in 24-h collections of urine from patients with carcinoid tumours: characterization and correlation with plasma concentrations.
Bergstrom M; Theodorsson E; Norheim I; Oberg K
Scand J Clin Lab Invest; 1995 Dec; 55(8):679-89. PubMed ID: 8903838
[TBL] [Abstract][Full Text] [Related]
9. Increased intestinal non-substance P tachykinin concentrations in malignant midgut carcinoid disease.
Makridis C; Theodorsson E; Akerström G; Oberg K; Knutson L
J Gastroenterol Hepatol; 1999 May; 14(5):500-7. PubMed ID: 10355517
[TBL] [Abstract][Full Text] [Related]
10. Chemical and immunochemical characterisation of substance P-like immunoreactivity and physalaemin-like immunoreactivity in a carcinoid tumour.
Conlon JM; Schäfer G; Schmidt WE; Lazarus LH; Becker HD; Creutzfeldt W
Regul Pept; 1985 Jun; 11(2):117-32. PubMed ID: 2412263
[TBL] [Abstract][Full Text] [Related]
11. Neurokinin A, neurokinin B and neuropeptide K in the rabbit iris: a study comparing different extraction methods.
Beding-Barnekow B; Brodin E
Regul Pept; 1989 May; 25(2):199-206. PubMed ID: 2547226
[TBL] [Abstract][Full Text] [Related]
12. Immunochemical characterisation of tachykinin immunoreactivity in the nervous system of the garden snail, Helix aspersa.
Leung PS; Shaw C; Johnston CF; Irvine GB
Comp Biochem Physiol C Comp Pharmacol Toxicol; 1992 Sep; 103(1):169-73. PubMed ID: 1280545
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptide K-(1-24)-peptide: storage and release by carcinoid tumors.
Conlon JM; Deacon CF; Grimelius L; Cedermark B; Murphy RF; Thim L; Creutzfeldt W
Peptides; 1988; 9(4):859-66. PubMed ID: 3226960
[TBL] [Abstract][Full Text] [Related]
14. Presence of IGF-I in human midgut carcinoid tumours--an autocrine regulator of carcinoid tumour growth?
Nilsson O; Wängberg B; Theodorsson E; Skottner A; Ahlman H
Int J Cancer; 1992 May; 51(2):195-203. PubMed ID: 1314781
[TBL] [Abstract][Full Text] [Related]
15. Circulating tachykinins (substance P, neurokinin A, neuropeptide K) and the carcinoid flush.
Conlon JM; Deacon CF; Richter G; Stöckmann F; Creutzfeldt W
Scand J Gastroenterol; 1987 Jan; 22(1):97-105. PubMed ID: 2882598
[TBL] [Abstract][Full Text] [Related]
16. Effect of a long-acting somatostatin analogue (octreotide) on circulating tachykinins and the pentagastrin-induced carcinoid flush.
Balks HJ; Conlon JM; Creutzfeldt W; Stöckmann F
Eur J Clin Pharmacol; 1989; 36(2):133-7. PubMed ID: 2470592
[TBL] [Abstract][Full Text] [Related]
17. The effects of neurokinin A, neurokinin B, and eledoisin on substance P analysis.
Naukam RJ; Parris WC; Kambam JR; Kruskal JB
J Clin Monit; 1991 Apr; 7(2):181-5. PubMed ID: 1712834
[TBL] [Abstract][Full Text] [Related]
18. Antisera raised against eledoisin and kassinin detect elevated levels of immunoreactive material in plasma and tumor tissues from patients with carcinoid tumors.
Norheim I; Theodorsson-Norheim E; Brodin E; Oberg K; Lundqvist G; Rosell S
Regul Pept; 1984 Nov; 9(4):245-57. PubMed ID: 6084259
[TBL] [Abstract][Full Text] [Related]
19. Antisera raised against eledoisin and kassinin detect immunoreactive material in rat tissue extracts: tissue distribution and chromatographic characterization.
Theodorsson-Norheim E; Brodin E; Norheim I; Rosell S
Regul Pept; 1984 Nov; 9(4):229-44. PubMed ID: 6596662
[TBL] [Abstract][Full Text] [Related]
20. Calcium-dependent potassium-stimulated release of neurokinin A and neurokinin B from rat brain regions in vitro.
Lindefors N; Brodin E; Theodorsson-Norheim E; Ungerstedt U
Neuropeptides; 1985 Sep; 6(5):453-61. PubMed ID: 2997657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]